Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials
Conclusion:
Use of MRAs alone or on top of RAS blockade confers important antiproteinuric effects in patients with CKD, with a slight increase in mean potassium levels.
Source: Journal of Hypertension - Category: Cardiology Tags: REVIEWS AND META-ANALYSES Source Type: research
More News: Calcium | Cardiology | Chronic Kidney Disease | Clinical Trials | Databases & Libraries | Hypertension | Potassium | Proteinuria | Urology & Nephrology